[go: up one dir, main page]

WO2019004968A3 - Use of a vegetal formulation containing pomegranate seed oil as an immune system enhancer due to its antioxidant function - Google Patents

Use of a vegetal formulation containing pomegranate seed oil as an immune system enhancer due to its antioxidant function Download PDF

Info

Publication number
WO2019004968A3
WO2019004968A3 PCT/TR2018/050157 TR2018050157W WO2019004968A3 WO 2019004968 A3 WO2019004968 A3 WO 2019004968A3 TR 2018050157 W TR2018050157 W TR 2018050157W WO 2019004968 A3 WO2019004968 A3 WO 2019004968A3
Authority
WO
WIPO (PCT)
Prior art keywords
seed oil
vegetal
pomegranate seed
immune system
antioxidant function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/TR2018/050157
Other languages
French (fr)
Other versions
WO2019004968A9 (en
WO2019004968A2 (en
Inventor
Mevlüt Büyükhelvacigi̇l
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helvacizade Gida Ilac Kimya Sanayi Ve Ticaret AS
Original Assignee
Helvacizade Gida Ilac Kimya Sanayi Ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helvacizade Gida Ilac Kimya Sanayi Ve Ticaret AS filed Critical Helvacizade Gida Ilac Kimya Sanayi Ve Ticaret AS
Publication of WO2019004968A2 publication Critical patent/WO2019004968A2/en
Publication of WO2019004968A3 publication Critical patent/WO2019004968A3/en
Publication of WO2019004968A9 publication Critical patent/WO2019004968A9/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to the use of a vegetal formulation in the pharmaceutical industry prepared in capsule form by using pomegranate seed oil rich in essential fatty acids such as punicic acid (Omega 5) as an immune system enhancer due to the formulation's antioxidant function in protection of health which comprises pomegranate seed oil, dl a-tocopherol, dl a-tocopheryl acetate, glycerine, purified water and gelatin that procures the integrity of the content and the capsulated formation.
PCT/TR2018/050157 2017-04-19 2018-04-10 Use of a vegetal formulation containing pomegranate seed oil as an immune system enhancer due to its antioxidant function Ceased WO2019004968A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2017/05828 2017-04-19
TR2017/05828A TR201705828A2 (en) 2017-04-19 2017-04-19 USAGE OF AN IMPROVEMENT OF IMMUNE SYSTEM AS AN ANTIOXIDANT PROPERTIES OF A VEGETABLE FORMULATION CONTAINING Pomegranate Seed Oil

Publications (3)

Publication Number Publication Date
WO2019004968A2 WO2019004968A2 (en) 2019-01-03
WO2019004968A3 true WO2019004968A3 (en) 2019-02-14
WO2019004968A9 WO2019004968A9 (en) 2019-04-11

Family

ID=64743059

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2018/050157 Ceased WO2019004968A2 (en) 2017-04-19 2018-04-10 Use of a vegetal formulation containing pomegranate seed oil as an immune system enhancer due to its antioxidant function

Country Status (2)

Country Link
TR (1) TR201705828A2 (en)
WO (1) WO2019004968A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1011021B (en) * 2024-01-17 2025-09-01 Στεφανος Θεοδωρου Κασσιδης Pomegranate seed oil production method

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104189283A (en) * 2014-09-04 2014-12-10 上海浦东高星生物技术研究所 Pomegranate seed oil drop pill
CN105963350A (en) * 2016-03-16 2016-09-28 安徽珠峰生物科技有限公司 A natural vitamin e soft capsule

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104189283A (en) * 2014-09-04 2014-12-10 上海浦东高星生物技术研究所 Pomegranate seed oil drop pill
CN105963350A (en) * 2016-03-16 2016-09-28 安徽珠峰生物科技有限公司 A natural vitamin e soft capsule

Also Published As

Publication number Publication date
WO2019004968A9 (en) 2019-04-11
WO2019004968A2 (en) 2019-01-03
TR201705828A2 (en) 2017-07-21

Similar Documents

Publication Publication Date Title
PH12020550341A1 (en) Niraparib formulations
BR112012026758A2 (en) capsule, method for producing capsules with a core / shell structure, uses of capsules with a core / shell structure, and powdery or liquid preparations, and pharmaceutical composition, cosmetics, crop protection preparation, animal feed, food or nutritional supplement
NZ741022A (en) Flavonoid compositions and methods of use
BR112012026596A2 (en) A method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and compositions comprising them.
EP4445959A3 (en) Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation
RU2014119376A (en) NEW COATING SYSTEM
US8518438B2 (en) Highly concentrated liquid acetaminophen solutions
WO2019023039A3 (en) Compositions for enhancing bioavailability of pharmaceuticals, supplements and ingested substances
PH12017500269B1 (en) Composite formulation for oral administration comprising omega-3 fatty acid esters and statins
NO20084478L (en) Conjugated Lipid Derivatives
WO2019004968A3 (en) Use of a vegetal formulation containing pomegranate seed oil as an immune system enhancer due to its antioxidant function
PE20220942A1 (en) COMPOSITION OF A SMALL-MOLECULE PI4KIIIalpha INHIBITOR, METHOD OF PREPARATION AND APPLICATION OF THE SAME
HRP20171485T1 (en) PHARMACEUTICAL PRODUCTS CONTAINING ALISPORIVIR
US9925229B1 (en) Anti-aging composition method
ATE452120T1 (en) FATTY ACID BENZENEDIOL DERIVATIVES AND PRODUCTION AND USE PROCESSES THEREOF
WO2019004969A3 (en) Use of a vegetal formulation containing pomegranate seed oil as an assistive agent in reduction of blood lipids known as triglyceride
JP6602578B2 (en) Oral composition
RU2016112012A (en) LUBRICANT COMPOSITION FOR MOUTH
MX387178B (en) VITAMIN PREPARATIONS CONTAINING PROPYL GALLATE.
UA117416C2 (en) MEDICINAL IN THE FORM OF SYRUP FOR THE ORAL APPLICATION OF A WIDE SPECTRUM OF ACTION
HK1221598A2 (en) Oral pharmaceutical composition and method of treating or preventing disease
EA201692398A1 (en) HOMOGENE COMPOSITION FOR ORAL ADMINISTRATION, CONTAINING OMEGA-3 POLYINSATURATED FATTY ACIDS AND RESVERATROL
AR097148A1 (en) FOOD COMPOSITION FOR RUMINANTS AND METHOD TO PREPARE IT
WO2018222167A3 (en) Use of a herbal formulation containing linseed oil in the treatment of cardiovascular system diseases
WO2018226192A3 (en) Use of a herbal formulation containing linseed oil on those who cannot use fish oil, particularly on vegetarians as a herbal omega 3 (ala) source

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18823680

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18823680

Country of ref document: EP

Kind code of ref document: A2